Monkeypox Outbreak Bulletin

by EnvirOx
Monkeypox Outbreak Bulletin

Recently, you may have heard about isolated outbreaks of monkeypox. Such outbreaks are rare and, as you might expect, there are presently few, if any, disinfectants that have a kill claim for monkeypox. As such, the EPA has activated the emerging viral pathogen protocol that allows existing disinfectants that meet certain criteria to be used. They have also created a List Q to identify products that are expected to be effective against monkeypox similar to the List N created for SARS-Covid-2. Details can be found in the link below:

To make things simple for our customers outlined below are our disinfectant products that are approved for List Q and the dilutions and contact times required to ensure effectiveness against monkeypox. Remember when searching List Q to use only the first two sets of numbers of the EPA Registration number e.g. 71847-6 to search 71847-6-69268.

Emerging Pathogen Claim: Monkeypox

Enveloped Virus

List Q


EPA Registration # Product Dilution Contact Time Supporting Virus
71847-6-69268 Broad Spectrum Disinfectant/Virucide Tablets 2153ppm (minimum) 1 min Norovirus
6836-349-69268 Broad Spectrum Disinfectant 256 Concentrate 1:128 5 min Norovirus
72977-3-69268 Critical Care RTU NA 3 min Adenovirus Type 2
1839-83-69268 TB Disinfectant RTU NA 3 min Human Rotovirus

The above products have demonstrated effectiveness against viruses similar to the monkeypox virus on hard non-porous surfaces.

Therefore these products can be used against monkeypox when used in accordance with the directions for use against the supporting virus on hard, non-porous surfaces.

For more information:

Refer to CDC website at

Refer to EPA website at

Call EnvirOx at 1-800-281-9604

Download this bulletin

Download this technical bulletin as a printable PDF.


EnvirOx Customers Get Exclusive Access to Our Online Training Portal